clairemharvey
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

clairemharvey

Forum Replies Created

Viewing 1 reply thread
  • Replies
      • July 5, 2011 at 10:42 pm
      clairemharvey
      Participant

        Report:

         

        Diagnosis: Melanoma, non ulcerated, Nodular Type, Clarks Level II/III, Breslow thickness 0.6mm (172.7)

         

        Microscopic description

         

        sections show a proliferation of atypical epithelioid melanocytes arrayed along the dermoepidermal junctions as single cells and regular/irregular sized/shaped nests with pagetoid migration evident. Nests of similar appearing cells are present in the subajacent dermis. There is chronic inflammation in the superficial dermis. No mitotic figures are apparent in the dermal component.

         

        That's it. No discussion of margins. I have since read that it is not mandatory to include info on margins, but I have also read that residual cancer findings in the WLE can result in upstaging of the tumor. If my entire treatment protocol rests on this thickness, it would seem an important component of the path report! Seems a little lacking, in my humble, but frightened opinion.

        • July 5, 2011 at 10:42 pm
        clairemharvey
        Participant

          Report:

           

          Diagnosis: Melanoma, non ulcerated, Nodular Type, Clarks Level II/III, Breslow thickness 0.6mm (172.7)

           

          Microscopic description

           

          sections show a proliferation of atypical epithelioid melanocytes arrayed along the dermoepidermal junctions as single cells and regular/irregular sized/shaped nests with pagetoid migration evident. Nests of similar appearing cells are present in the subajacent dermis. There is chronic inflammation in the superficial dermis. No mitotic figures are apparent in the dermal component.

           

          That's it. No discussion of margins. I have since read that it is not mandatory to include info on margins, but I have also read that residual cancer findings in the WLE can result in upstaging of the tumor. If my entire treatment protocol rests on this thickness, it would seem an important component of the path report! Seems a little lacking, in my humble, but frightened opinion.

      Viewing 1 reply thread
      About the MRF Patient Forum

      The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

      The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

      Popular Topics